Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (311-320 of 404) with videos related to

Pageof 41
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
The Lancet. Gastroenterology & Hepatology|March 18, 2022
Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
Journal of Hepatology|November 7, 2017
The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international studyMaryam Alavi, Naveed Z Janjua, Mei Chong, et al.
The International Journal on Drug Policy|December 21, 2022
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
Lancet (London, England)|June 8, 2014
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trialIra M Jacobson, Gregory J Dore, Graham R Foster, et al.
The Lancet. Global Health|November 16, 2023
Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic reviewBehzad Hajarizadeh, Abe Kairouz, Sophie Ottaviano, et al.
The Lancet. Microbe|June 19, 2023
Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysisJelle Koopsen, Gail Matthews, Juergen Rockstroh, et al.
Open Forum Infectious Diseases|March 15, 2016
Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 CollaborativeKimberly Page, Ali Mirzazadeh, Thomas M Rice, et al.
AIDS (London, England)|July 17, 2007
Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infectionGregory J Dore, Francesca J Torriani, Maribel Rodriguez-Torres, et al.
Hepatology (Baltimore, Md.)|June 24, 2008
Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistanceScott Preiss, Margaret Littlejohn, Peter Angus, et al.
Pageof 41

Showing results (311-320 of 404) with videos related to

Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
The Lancet. Gastroenterology & Hepatology|March 18, 2022
Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
Journal of Hepatology|November 7, 2017
The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international studyMaryam Alavi, Naveed Z Janjua, Mei Chong, et al.
The International Journal on Drug Policy|December 21, 2022
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
Lancet (London, England)|June 8, 2014
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trialIra M Jacobson, Gregory J Dore, Graham R Foster, et al.
The Lancet. Global Health|November 16, 2023
Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic reviewBehzad Hajarizadeh, Abe Kairouz, Sophie Ottaviano, et al.
The Lancet. Microbe|June 19, 2023
Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysisJelle Koopsen, Gail Matthews, Juergen Rockstroh, et al.
Open Forum Infectious Diseases|March 15, 2016
Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 CollaborativeKimberly Page, Ali Mirzazadeh, Thomas M Rice, et al.
AIDS (London, England)|July 17, 2007
Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infectionGregory J Dore, Francesca J Torriani, Maribel Rodriguez-Torres, et al.
Hepatology (Baltimore, Md.)|June 24, 2008
Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistanceScott Preiss, Margaret Littlejohn, Peter Angus, et al.
Pageof 41